Join to access to all OVN content. Join for Free
Insight about INSIGHTS, and how they can help your MSL career!
MSL insights medical affairs career digital tools in field medical hybrid MSL interactions evolving MSL role

Insight about INSIGHTS, and how they can help your MSL career!


Share This Article


Summary

In this episode, Joe Liberman shares his journey from MSL to Associate Director, offering valuable advice on transitioning roles within medical affairs. He delves into the role of an Insights Lead, emphasizing the significance of MSL insights and how to effectively gather and report them. Joe discusses the impact of insights on MSL performance evaluation and provides year-end performance advice. The conversation shifts to the influence of digital tools on field medical, adaptation strategies, and the future of MSL interactions in a hybrid model. Joe concludes with reflections on the evolving role of MSLs with emerging technologies, expressing gratitude and appreciation.

Joe Liberman, Associate  Director, Medical Affairs at UniQure discusses MSL insights and how they can help your career.

Joe shares…

👉 What makes a good MSL Insight and why they are so important

👉 How to effectively go about gathering Insights

👉 Best practices for reporting insights

👉 Advice on how to find success and improve performance

👉 What MSL can expect for 2022

Click for Source
MSL insights, medical affairs career, digital tools in field medical, hybrid MSL interactions, evolving MSL role

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
How to Leverage YOUR Unique Skills for Career Advantage
Partner Avatar MSL Talk: Tom Caravela, Hahn-Ey Lee

How to Leverage YOUR Unique Skills for Career Advantage

Podcast
A Trip Around the MSL Insights Cycle
Partner Avatar MSL Talk: Tom Caravela

A Trip Around the MSL Insights Cycle

Article
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
OVN Avatar Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH

Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions

Article
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
OVN Avatar Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin

Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years

Article
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
OVN Avatar Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS

Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review

Article
Transforming oncology: Five frontiers driving progress in cancer care
Partner Avatar iNIZIO

Transforming oncology: Five frontiers driving progress in cancer care

Explore OVN